Worldwide variations in EGFR somatic mutations: a challenge for personalized medicine
Two studies recently reported around 10% of EGFR activating mutations in triple negative breast cancers from Asian patients. However, we did not find any EGFR activating mutation in a series of 229 breast tumor samples from European patients. Like in lung cancer, the EGFR mutation profiles seem to b...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BioMed Central
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277478/ |